Related Experiment Videos
[Implication of non-perforating deep sclerectomy with amniotic membrane implantation for primary open-angle glaucoma]
Wen Ye1, Jingfeng Sun, Yisheng Zhong
1The Department of Ophthalmology, Ruijin Hospital affiliated Shanghai Second Medical University, Shanghai 200025, China.
Yan Ke Xue Bao = Eye Science
|October 30, 2004
Summary
Non-perforating deep sclerectomy with amniotic membrane implantation effectively lowers intraocular pressure in primary open-angle glaucoma patients. This safe procedure shows sustained efficacy over 12 months.
Area of Science:
- Ophthalmology
- Glaucoma Research
- Surgical Innovation
Context:
- Primary open-angle glaucoma (POAG) is a leading cause of irreversible blindness.
- Effective IOP-lowering surgical techniques are crucial for POAG management.
- Non-perforating deep sclerectomy (NPDS) is a surgical option for glaucoma treatment.
Purpose:
- To evaluate the efficacy and safety of non-perforating deep sclerectomy (NPDS) combined with amniotic membrane implantation for treating primary open-angle glaucoma (POAG).
Summary:
- This study assessed NPDS with amniotic membrane implantation in 23 eyes with POAG.
- Postoperative intraocular pressure (IOP) control was achieved in all eyes at 1 month.
- Sustained IOP reduction was observed over 12 months, with a 66.7% success rate, and no serious complications were reported.
Impact:
- Amniotic membrane serves as a safe and effective material for implantation during NPDS.
- This surgical approach offers a viable option for managing POAG with good long-term outcomes.
- Further research can explore optimizing NPDS techniques with biological materials for enhanced glaucoma control.